Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.

<h4>Background</h4>Reoccurring Ebola outbreaks in West and Central Africa have led to serious illness and death in thousands of adults and children. The objective of this study was to assess safety, tolerability, and immunogenicity of the heterologous 2-dose Ad26.ZEBOV, MVA-BN-Filo vaccination regim...

全面介紹

書目詳細資料

Principais autores:	Zacchaeus Anywaine, Houreratou Barry, Omu Anzala, Gaudensia Mutua, Sodiomon B Sirima, Serge Eholie, Hannah Kibuuka, Christine Bétard, Laura Richert, Christine Lacabaratz, M Juliana McElrath, Stephen C De Rosa, Kristen W Cohen, Georgi Shukarev, Michael Katwere, Cynthia Robinson, Auguste Gaddah, Dirk Heerwegh, Viki Bockstal, Kerstin Luhn, Maarten Leyssen, Rodolphe Thiébaut, Macaya Douoguih, EBL2002 Study group
格式:	Artigo
語言:	Inglês
出版:	Public Library of Science (PLoS) 2022-01-01
叢編:	PLoS Medicine
在線閱讀:	https://doi.org/10.1371/journal.pmed.1003865
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!